A microdialysis study of the in vivo release of 5-HT in the median raphe nucleus of the rat

British Journal of Pharmacology

Volumn 125, Issue 6, 1998, Pages 1361-1367

  Adell, Albert ^a   Artigas, Francesc ^a  

^a INST D INVESTIGACIONS B   (Spain)

Author keywords

5 HT; 5 HT(1A) receptors; 8 OH DPAT; BAY x 3702; EEDQ; Median raphe nucleus; Microdialysis; Reserpine; TTX; WAY 100635

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 2 ETHOXY 1(2H) QUINOLINECARBOXYLIC ACID ETHYL ESTER; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; RESERPINE; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; TETRODOTOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; MALE; MEDIAN RAPHE NUCLEUS; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE;

EID: 0031797154     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702206     Document Type: Article

References (61)

1. ADELL, A. & ARTIGAS, F. (1991). Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study. Naunyn-Schmiedeberg's Arch. Pharmacol., 343, 237-244.
2. ADELL, A., CARCELLER, A. & ARTIGAS, F. (1993). In vivo brain dialysis study of the somatodendritic release of serotonin in the raphe nuclei of the rat: effects of 8-hydroxy-2-(di-n-propylamino)tetralin. J. Neurochem., 60, 1673-1681.
3. ADELL, A., CASANOVAS, J.M. & ARTIGAS, F. (1997). Comparative-study in the rat of the actions of different types of stress on the release of 5-HT in raphe nuclei and forebrain areas. Neuropharmacology, 36, 735-741.
4. ADELL, A., SARNA, G.S., HUTSON, P.H. & CURZON G. (1989). An in vivo dialysis and behavioural study of the release of 5-HT hy p-chloroamphelamine in reserpine-treated rats. Br. J. Pharmacol., 97, 206-212.
5. 1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rat treated acutely or chronically with citalopram. Naunyn-Schmiedeberg's Arch. Pharmacol., 352, 157-165.
6. ASSIÉ, M.-B. & KOEK, W. (1996). Possible in vivo 5-HT reuptake blocking properties of 8-OH-DPAT assessed by measuring hippocampal extracellular 5-HT using microdialysis in rats. Br. J. Pharmacol., 119, 845-850.
7. AZMITIA, E.C. & SEGAL, M. (1978). An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J. Comp. Neurol., 179, 641-668.
8. 1A agonist gepirone: electrophysiological studies in the rat brain. Synapse, 1, 470-480.
9. 1 receptor agonists and p-chloroamphetamine. Synapse, 5, 120-133.
10. BOBILLIER, P., PETITJEAN, F., SALVERT, D., LIGIER, M. & SEGUIN, S. (1975). Differential projections of the nucleus raphe dorsalis and nucleus raphe centralis as revealed by auloradiography. Brain Res., 85, 205-210.
11. 1A receptors. J. Neurochem., 66, 2546-2555.
12. BOSKER, F., KLOMPMAKERS, A. & WESTENBERG, H. (1994). Extracellular 5-hydroxytryptamine in median raphe nucleus of the conscious rat is decreased by nanomolar concentrations of 8-hydroxy-2-(di-n-propylamino)tetralin and is sensitive to tetrodotoxin. J. Neurochem., 63, 2165-2171.
13. CARBONI, E. & DI CHIARA, G. (1989). Serotonin release estimated by transcortical dialysis in freely-moving rats. Neuroscience, 32, 637-645.
14. CASANOVAS, J.M. & ARTIGAS, F. (1996). Differential effects of ipsapirone on 5-hydroxytryptamine release in the dorsal and median raphe neuronal pathways. J. Neurochem., 67, 1945-1952.
15. 1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain. Br. J. Pharmacol., 122, 733-741.
16. CECI, A., BASCHIROTTO, A. & BORSINI, F. (1994). The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe neurons in rats is attenuated by lesion of the frontal cortex. Neuropharmacology, 33, 709-713.
17. CHAZAL, G. & RALSTON III, H.J. (1987). Serotonin-containing structures in the nucleus raphe dorsalis of the cat: an ultrastructural analysis of dendrites, presynaptic dendrites, and axon terminals. J. Comp. Neurol., 259, 317-329.
18. CHEN, N.H. & REITH, M.E.A. (1994). Effects of locally applied cocaine, lidocaine, and various uptake blockers on monoamine transmission in the ventral tegmental area of freely moving rats: a microdialysis study on monoamine interrelationships. J. Neurochem., 63, 1701-1713.
19. 3H]5-hydroxytryptamine into rat cortical synaptosomes. Eur. J. Pharmacol., 239, 211-214.
20. CORRADETTI, R., LE POUL, E., LAARIS, N., HAMON, M. & LANFUMEY, L. (1996). Electrophysiological effects of N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl) cyclohexane carboxamide (WAY 100635) on dorsal raphe serotonergic neurons and CA1 hippocampal pyramidal cells in vitro. J. Pharmacol. Exp. Ther., 278, 679-688.
21. 1A agonists. Synapse, 14, 297-304.
22. 1A receptor agonist. J. Pharmacol. Exp. Ther., 284, 1082-1094.
23. DI CHIARA, G. (1996). Estimation of in-vivo neurotransmitter release by brain microdialysis: the issue of validity. Behav. Pharmacol., 7, 640-657.
24. DILTS, R.P. & BOADLE-BIBER, M.C. (1995). Differential activation of the 5-hydroxytryptamine-containing neurons of the midbrain raphe of the rat in response to randomly presented inescapable sound. Neurosci. Lett., 199, 78-80.
25. 1A receptor antagonist. Behav. Brain Res., 73, 337-353.
26. 1A antagonist, increases setotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135. J. Pharmacol. Exp. Ther., 278, 752-762.
27. 1A receptor antagonist, WAY-100635. Eur. J. Pharmacol., 281, 81-88.
28. GARTSIDE, S.E., MCQUADE, R, & SHARP, T. (1996). Effects of repeated administration of 3,4-methylenedioxymethamphetamine on 5-hydroxytryptamine neuronal activity and release in the rat brain in vivo. J. Pharmacol. Exp. Ther., 279, 277-283.
29. 1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br. J. Pharmacol., 115, 1064-1070.
30. GOZLAN, H., LAPORTE, A.-M., THIBAULT, S., SCHECHTER, L.E., BOLAÑOS, F. & HAMON, M. (1994). Differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain. Neuropharmacology, 33, 423-431.
31. HAJÓS, M., GARTSIDE, S. & SHARP, T. (1995). Inhibition of median and dorsal raphe neurones following administration of the selective serotonin reuptake inhibitor paroxetine. Naunyn-Schmiedeberg's Arch. Pharmacol., 351, 624-629.
32. HAMON, M., BOURGOIN, S., GOZLAN, H., HALL, M.D., GOETZ, C., ARTAUD, F. & HORN, A.S. (1984). Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)-tetralin) in the rat brain. Eur. J. Pharmacol., 100, 263-276.
33. HENSLER, J.G., FERRY, R.C., LABOW, D.M., KOVACHICH, G.B. & FRAZER, A. (1994). Quantitative autoradiography of the serotonin transporter to assess the distribution of serotonergic projections from the dorsal raphe nucleus. Synapse, 17, 1-15.
34. HÉRY, F., FAUDON, M. & TERNAUX, J.P. (1982). In vivo release of serotonin in two raphe nuclei (raphe dorsalis and magnus) of the cat. Brain Res. Bull., 8, 123-129.
35. HESLOP, K.E. & CURZON, G. (1994). Depletion and repletion of cortical tissue and dialysate 5-HT after reserpine. Neuropharmacology, 33, 567-573.
36. HILLEGAART, V., HJORTH, S. & AHLENIUS, S. (1990). Effects of 5-HT and 8-OH-DPAT on forebrain monoamine synthesis after local application into the median and dorsal raphe nuclei of the rat. J. Neural Transm. [Gen. Sect.], 81, 131-145.
37. IMAI, H., STEINDLER, D.A. & KITAI, S.T. (1986). The organization of divergent axonal projections from the midbrain raphe nuclei in the rat. J. Comp. Neurol., 243, 363-380.
38. INVERNIZZI, R., CARLI, M., DI CLEMENTE, A. & SAMANIN, R. (1991). Administration of 8-hydroxy-2-(di-n-propylamino)tetralin in raphe nuclei dorsalis and medianus reduces serotonin synthesis in the rat brain: differences in potency and regional sensitivity. J. Neurochem., 56, 243-247.
39. JACOBS, B.L. & AZMITIA, E.C. (1992). Structure and function of the brain serotonin system. Physiol. Rev., 72, 165-229.
40. KÖHLER, C., CHAN-PALAY, V. & STEINBUSCH, H. (1982). The distribution and origin of serotonin-containing fibers in the septal area: a combined immunohistochemical and fluorescent retrograde tracing study in the rat. J. Comp. Neurol., 209, 91-111.
41. KOSOFSKY, B.E. & MOLLIVER, M.E. (1987). The serotoninergic innervation of cerebral cortex: different classes of axon terminals arise from dorsal and median raphe nuclei. Synapse, 1, 153-168.
42. 1A autoreceptors of the dorsal and median raphe nuclei. J. Pharmacol. Exp. Ther., 269, 1268-1279.
43. LONG, J.B., YOUNGBLOOD, W.Y. & KIZER, J.S. (1983). Regional differences in the response of serotonergic neurons in rat CNS to drugs. Eur. J. Pharmacol., 88, 89-97.
44. 1A receptors in the dorsal raphe nucleus. Eur. J. Pharmacol., 149, 9-15.
45. MAMOUNAS, L.A. & MOLLIVER, M.E. (1988). Evidence for dual serotonergic projections to neocortex: axons from the dorsal and median raphe nuclei are differentially vulnerable to the neurotoxin p-chloroamphetamine (PCA). Exp. Neurol., 102, 23-36.
46. MAMOUNAS, L.A., MULLEN, C.A., O'HEARN, E. & MOLLIVER, M.E. (1991). Dual serotonergic projections to the forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives. J. Comp. Neurol., 314, 558-586.
47. MARTÍN, F. & ARTIGAS, F. (1992). Simultaneous effects of p-chloroamphetamine, d-fenfluramine, and reserpine on free and stored 5-hydroxytryptamine in brain and blood. J. Neurochem., 59, 1138-1144.
48. MATOS, F.F., URBAN, C. & YOCCA, F.D. (1996). Serotonin (5-HT) release in the dorsal raphé and ventral hippocampus: raphé control of somatodendritic and terminal 5-HT release. J. Neural Transm., 103, 173-190.
49. MCQUADE, R. & SHARP, T. (1997). Functional mapping of dorsal and median raphe 5-hydroxytryptamine pathways in forebrain of the rat using microdialysis. J. Neurochem., 69, 791-796.
50. 1A agonists. Mol. Pharmacol., 37, 231-237.
51. NORMAN, A.B. & CREESE, I. (1986). Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain. Mol. Pharmacol., 30, 96-103.
52. NOWAK, G., ARNT, J. & HYTTEL, J. (1988). EEDQ, a tool for ex vivo measurement of occupancy of D-1 and D-2 dopamine receptors. Eur. J. Pharmacol., 153, 309-311.
53. PAXINOS, G. & WATSON, C. (1986). The Rat Brain in Stereotaxic Coordinates. Sydney: Academic Press.
54. PILC, A. & VETULANI, J. (1990). Pretreatment with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline accelerates the electroshock-induced decrease in density of β-adrenoceptors but not functional downregulation. Neuropharmacology, 29, 469-473.
55. PINTO, W. & BATTAGLIA. G. (1993). In vivo EEDQ dose-dependently inactivates rat brain 5-HT receptors but not 5-HT uptake sites. Neuro Report, 5, 61-64.
56. 1A receptor mRNA after irreversible inactivation with EEDQ. Mol. Brain Res., 38, 233-242.
57. 1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain. Neuropsychopharmacology, 15, 349-360.
58. o proteins in dorsal raphe nucleus. Eur J. Pharmacol., 265, 103-106.
59. SHARP, T., BRAMWELL, S.R., HJORTH, S. & GRAHAME-SMITH D.G. (1989). Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis. Br. J. Pharmacol., 98, 989-997.
60. SHORE, P.A. & GIACHETTI, A. (1978). Reserpine: basic and clinical pharmacology. In Handbook of Psychopharmacology, Vol. 10, eds. Iversen, L.L., Iversen, S.D. & Snyder, S.H. pp. 197-219. New York: Plenum Press.
61. 1 receptor. Eur. J. Pharmacol., 157, 173-181.